| Product Code: ETC9568940 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Overview |
3.1 Sweden Country Macro Economic Indicators |
3.2 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, 2021 & 2031F |
3.3 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market - Industry Life Cycle |
3.4 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market - Porter's Five Forces |
3.5 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investment in mRNA therapeutics research and development |
4.2.2 Growing prevalence of chronic diseases driving demand for mRNA therapeutics |
4.2.3 Advancements in technology and manufacturing processes for mRNA therapeutics |
4.3 Market Restraints |
4.3.1 Regulatory challenges and uncertainties surrounding mRNA therapeutics |
4.3.2 High cost associated with development and manufacturing of mRNA therapeutics |
4.3.3 Limited expertise and infrastructure for mRNA therapeutics manufacturing in Sweden |
5 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Trends |
6 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market, By Types |
6.1 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Viral Vaccines, 2021- 2031F |
6.1.4 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Protein Replacement Therapies, 2021- 2031F |
6.1.5 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Cancer Immunotherapies, 2021- 2031F |
6.2 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Infectious Diseases, 2021- 2031F |
6.2.3 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Metabolic & Genetic Diseases, 2021- 2031F |
6.2.4 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenues & Volume, By Cardiovascular & Cerebrovascular Diseases, 2021- 2031F |
7 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Import-Export Trade Statistics |
7.1 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Export to Major Countries |
7.2 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Imports from Major Countries |
8 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Key Performance Indicators |
8.1 Number of partnerships and collaborations with pharmaceutical companies for mRNA therapeutics development |
8.2 Rate of adoption of mRNA therapeutics in clinical trials and healthcare settings |
8.3 Number of new entrants in the Sweden mRNA therapeutics CDMO market |
8.4 Efficiency and capacity utilization of manufacturing facilities |
8.5 Number of successful regulatory approvals for mRNA therapeutics products |
9 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market - Opportunity Assessment |
9.1 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market - Competitive Landscape |
10.1 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Revenue Share, By Companies, 2024 |
10.2 Sweden mRNA Therapeutics Contract Development & Manufacturing Organization Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here